Role of mean platelet volume in triagging acute coronary syndromes.
BACKGROUND
Acute coronary syndromes, characterized by the rupture of unstable plaque and the subsequent thrombotic process involving platelets, have been increasing in relative frequency. The central role of platelet activation has long been noticed in this pathophysiology; hence, many therapies have been directed against it. In this study, we have aimed to search prospectively the value of mean platelet volume (MPV), which is a simple and accurate measure of the functional status of platelets, in patients hospitalized with diagnosis of acute coronary syndromes (ACS).


METHODS
A total of 216 consecutive patients (156 male, 60 female) hospitalized with the diagnosis of non-ST segment elevation (NSTE) ACS within the first 24 h of their chest pain were enrolled. One hundred and twenty patients, matched according to sex and age, with stable coronary heart disease (CHD) (85 male, 35 female) were enrolled as a control group. Patients were classified into two group: those with unstable angina (USAP, n = 105) and those with non-ST segment elevation myocardial infarction (NSTEMI, n = 111).


RESULTS
MPVs were 10.4 +/- 0.6 fL, 10 +/- 0.7 fL, 8.9 +/- 0.7 fL consecutively for NSTEMI, USAP and stable CHD with significant differences. Patients with ischemic attacks in the first day of hospitalization accompanied by >0.05 mV ST segment shift had significantly higher MPV compared to those without such attacks (P = 0.001). Multivariable logistic regression analysis yielded that MPV (P = 0.016), platelet count (P < 0.001), and the presence of >0.05 mV ST segment depression at admission (P = 0.002) were independent predictors of development of NSTEMI in patients presenting with NSTE ACS.


CONCLUSIONS
In patients presenting with NSTE ACS, higher MPV, though there are overlaps among subgroups, indicates not only more risk of having NSTEMI but also ischemic complications.
Yilmaz
Mehmet Birhan
MB
Department of Cardiology, Cumhuriyet University, School of Medicine, Sivas, Turkey. cardioceptor@gmail.com
Cihan
Gokhan
G
Guray
Yesim
Y
Guray
Umit
U
Kisacik
Halil L
HL
Sasmaz
Hatice
H
Korkmaz
Sule
S
D054058:Acute Coronary Syndrome / Q000097:blood* / Q000150:complications / Q000628:therapy; D000368:Aged; D000789:Angina, Unstable / Q000097:blood / Q000209:etiology*; D001792:Blood Platelets / Q000473:pathology*; D016022:Case-Control Studies; D048429:Cell Size; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology*; D010976:Platelet Count; D010979:Platelet Function Tests; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D014218:Triage
Circulation. 1996 Nov 1;94(9):2083-9
8901655
J Pharmacol Exp Ther. 1982 Jul;222(1):276-81
7086705
J Clin Invest. 1972 May;51(5):1235-43
4262550
Am J Cardiol. 1999 Apr 15;83(8):1147-51
10215274
Br J Haematol. 1982 Mar;50(3):509-19
7066203
J Lab Clin Med. 1983 Feb;101(2):205-13
6822760
Lancet. 1991 Dec 7;338(8780):1409-11
1683417
N Engl J Med. 1984 May 3;310(18):1137-40
6709008
Clin Sci (Lond). 1985 Apr;68(4):419-25
3971672
Blood. 1988 Jul;72(1):1-8
3291975
Blood. 1978 Feb;51(2):307-16
620086
J Am Coll Cardiol. 2002 Oct 2;40(7):1366-74
12383588
Eur Heart J. 1998 Jan;19(1):80-4
9503179
Eur J Clin Invest. 1990 Apr;20(2):166-70
2112481
Thromb Res. 1983 Apr 15;30(2):157-64
6868020
J Vet Pharmacol Ther. 1994 Oct;17(5):374-8
7853463
N Engl J Med. 1986 Oct 16;315(16):983-9
3531859
Eur J Clin Invest. 1994 Jan;24(1):69-72
8187810
Thromb Res. 1983 Dec 1;32(5):443-60
6658722
J Clin Invest. 1969 Jun;48(6):1083-7
5771189
Blood. 1983 Aug;62(2):487-94
6871471
J Lab Clin Med. 1983 Feb;101(2):295-307
6822764
N Engl J Med. 1983 Aug 18;309(7):396-403
6135989
Thromb Res. 2006;117(4):371-7
15935453
J Clin Invest. 1969 Jun;48(6):1073-82
5771188
Br J Haematol. 1983 Mar;53(3):503-11
6402003